Rita is the CEO of Muna Therapeutics, a biotech company focused on discovering and developing therapies that restore the function of diseased neurons and slow or stop neurodegeneration.

In this conversation, we explore Rita’s career journey and what inspired their move into biotech leadership, as well as what first drew them to Muna Therapeutics. We talk about Muna’s scientific focus, how their approach to neurodegenerative diseases stands apart, and what it takes to lead a globally distributed team.

We also dive into the culture they’re building at Muna — one that encourages innovation and resilience — and look ahead at what’s next for the company over the coming year.